title: The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
abstract: BACKGROUND
  The gene that causes most cases of hereditary hemochromatosis is designated HFE. Three mutations exist at this locus at a relatively high gene frequency.
  
  
  OBJECTIVE
  To determine the gene frequency of the three HFE mutations and to relate genotypes to various clinical and laboratory variables.
  
  
  METHODS
  Observational study.
  
  
  METHODS
  Health appraisal clinic.
  
  
  METHODS
  10,198 adults who registered for health appraisal and consented to DNA examination for hemochromatosis. Consenting patients were slightly older and had attained a slightly higher educational level than nonconsenting patients.
  
  
  METHODS
  Extensive medical history and laboratory tests, including complete blood count, transferrin saturation, and other chemistries; serum ferritin levels; and HFE genotype.
  
  
  RESULTS
  In white participants, the gene frequencies were 0.063 for the C282Y mutation, 0.152 for the H63D mutation, and 0.016 for the S65C mutation. Gene frequencies were lower in other ethnic groups. In participants with HFE mutations, the average serum transferrin saturation and ferritin levels were slightly increased, as were mean hemoglobin levels and mean corpuscular volume. A transferrin saturation of 50% had a sensitivity of only 0.52 (95% CI, 0.345 to 0.686) and a specificity of 0.908 (CI, 0.902 to 0.914) for detection of homozygosity. A ferritin level of 200 microg/L in women and 250 microg/L in men had a sensitivity of 0.70 (CI, 0.540 to 0.854) and a specificity of 0.803 (CI, 0.796 to 0.811). The prevalence of iron deficiency anemia was lower in women who carried HFE mutations.
  
  
  CONCLUSIONS
  Screening for transferrin saturation and ferritin levels does not detect all homozygotes for the major hemochromatosis mutation. Heterozygotes for HFE mutations had a lower prevalence of iron deficiency anemia.
authors.affiliation: The Scripps Research Institute, La Jolla, California 92037, USA. beutler@scripps.edu
authors.forename: E
authors.initials: E
authors.lastname: Beutler
authors.forename: V
authors.initials: V
authors.lastname: Felitti
authors.forename: T
authors.initials: T
authors.lastname: Gelbart
authors.forename: N
authors.initials: N
authors.lastname: Ho
mesh_terms: D000554:Ambulatory Care Facilities; D002140:California; D004911:Erythrocyte Volume; D005006:Ethnicity; D005260:Female; D005293:Ferritins / Q000097:blood; D005805:Genes, MHC Class I; D005838:Genotype; D006680:HLA Antigens / Q000235:genetics; D006305:Health Status Indicators; D006432:Hemochromatosis / Q000235:genetics; D000071020:Hemochromatosis Protein; D006454:Hemoglobins / Q000032:analysis; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D019190:Iron Overload / Q000097:blood / Q000235:genetics*; D008297:Male; D008565:Membrane Proteins; D008875:Middle Aged; D009154:Mutation; D011795:Surveys and Questionnaires; D014168:Transferrin / Q000032:analysis
chemical_list: C103673:HFE protein, human; D006680:HLA Antigens; D000071020:Hemochromatosis Protein; D006454:Hemoglobins; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D014168:Transferrin; D005293:Ferritins